Pegfilgrastim Alternatives Compared
| Pegfilgrastim | Neulasta (pegfilgrastim) | Neupogen (filgrastim) |
|
|---|
| Pegfilgrastim | Neulasta (pegfilgrastim) | Neupogen (filgrastim) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Neutropenia Associated with Chemotherapy, Febrile Neutropenia, Neutropenia Associated with Radiation, Hematopoietic Syndrome of Acute Radiation Syndrome. Pegfilgrastim may also be used... View more |
Prescription only
Neulasta is used to reduce the risk of infection in people with non-myeloid malignancies receiving bone marrow-suppressing anti-cancer drugs associated with a high risk of febrile neutropenia or to... View more |
Prescription only
Prescribed for Neutropenia Associated with Chemotherapy, Neutropenia, Peripheral Progenitor Cell Transplantation, Bone Marrow Transplantation, Neutropenia Associated with Radiation, Hematopoietic... View more |
Related suggestions Hematopoietic Syndrome of Acute Radiation Syndrome
Neutropenia Associated with Radiation
|
|||||||||||||||
| More about Pegfilgrastim | More about Neulasta (pegfilgrastim) | More about Neupogen (filgrastim) | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Pegfilgrastim has an average rating of 4.9 out of 10 from a total of 78 ratings on Drugs.com. 38% of reviewers reported a positive effect, while 46% reported a negative effect. |
Neulasta has an average rating of 5.1 out of 10 from a total of 71 ratings on Drugs.com. 42% of reviewers reported a positive effect, while 45% reported a negative effect. |
Neupogen has an average rating of 10.0 out of 10 from a total of 3 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
View all Pegfilgrastim side effects |
View all Neulasta side effects |
View all Neupogen side effects |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Neulasta prices |
View all Neupogen prices |
||||||||||||||||
| Dosage Forms | ||||||||||||||||||
|
N/A |
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Fulphila, Fylnetra, Neulasta, Nyvepria, Stimufend, Udenyca, Ziextenzo | Other pegfilgrastim brands include: Fulphila, Fylnetra, Nyvepria, Stimufend, Udenyca, Ziextenzo | Other filgrastim brands include: Nivestym, Nypozi, Releuko, Zarxio | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
|
80 hours |
80 hours |
5.8 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 179 drugs are known to interact with Pegfilgrastim:
|
A total of 179 drugs are known to interact with Neulasta:
|
A total of 175 drugs are known to interact with Neupogen:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
N/A |
January 31, 2002 |
February 20, 1991 |
||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient Resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.